Pharmacological Applications of Bile Acids and Their Derivatives in the Treatment of Metabolic Syndrome

Apart from well-known functions of bile acids in digestion and solubilization of lipophilic nutrients and drugs in the small intestine, the emerging evidence from the past two decades identified the role of bile acids as signaling, endocrine molecules that regulate the glucose, lipid, and energy...

Full description

Bibliographic Details
Main Authors: Danic, M., Stanimirov, B., Pavlovic, N., Golocorbin-Kon, S., Al-Salami, Hani, Stankov, K., Mikov, M.
Format: Journal Article
Published: 2018
Online Access:http://hdl.handle.net/20.500.11937/74354
_version_ 1848763251557400576
author Danic, M.
Stanimirov, B.
Pavlovic, N.
Golocorbin-Kon, S.
Al-Salami, Hani
Stankov, K.
Mikov, M.
author_facet Danic, M.
Stanimirov, B.
Pavlovic, N.
Golocorbin-Kon, S.
Al-Salami, Hani
Stankov, K.
Mikov, M.
author_sort Danic, M.
building Curtin Institutional Repository
collection Online Access
description Apart from well-known functions of bile acids in digestion and solubilization of lipophilic nutrients and drugs in the small intestine, the emerging evidence from the past two decades identified the role of bile acids as signaling, endocrine molecules that regulate the glucose, lipid, and energy metabolism through complex and intertwined pathways that are largely mediated by activation of nuclear receptor farnesoid X receptor (FXR) and cell surface G protein-coupled receptor 1, TGR5 (also known as GPBAR1). Interactions of bile acids with the gut microbiota that result in the altered composition of circulating and intestinal bile acids pool, gut microbiota composition and modified signaling pathways, are further extending the complexity of biological functions of these steroid derivatives. Thus, bile acids signaling pathways have become attractive targets for the treatment of various metabolic diseases and metabolic syndrome opening the new potential avenue in their treatment. In addition, there is a significant effort to unveil some specific properties of bile acids relevant to their intrinsic potency and selectivity for particular receptors and to design novel modulators of these receptors with improved pharmacokinetic and pharmacodynamic profiles. This resulted in synthesis of few semi-synthetic bile acids derivatives such as 6a-ethyl-chenodeoxycholic acid (obeticholic acid, OCA), norursodeoxycholic acid (norUDCA), and 12-monoketocholic acid (12-MKC) that are proven to have positive effect in metabolic and hepato-biliary disorders. This review presents an overview of the current knowledge related to bile acids implications in glucose, lipid and energy metabolism, as well as a potential application of bile acids in metabolic syndrome treatment with future perspectives.
first_indexed 2025-11-14T11:00:30Z
format Journal Article
id curtin-20.500.11937-74354
institution Curtin University Malaysia
institution_category Local University
last_indexed 2025-11-14T11:00:30Z
publishDate 2018
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-743542019-06-25T00:48:53Z Pharmacological Applications of Bile Acids and Their Derivatives in the Treatment of Metabolic Syndrome Danic, M. Stanimirov, B. Pavlovic, N. Golocorbin-Kon, S. Al-Salami, Hani Stankov, K. Mikov, M. Apart from well-known functions of bile acids in digestion and solubilization of lipophilic nutrients and drugs in the small intestine, the emerging evidence from the past two decades identified the role of bile acids as signaling, endocrine molecules that regulate the glucose, lipid, and energy metabolism through complex and intertwined pathways that are largely mediated by activation of nuclear receptor farnesoid X receptor (FXR) and cell surface G protein-coupled receptor 1, TGR5 (also known as GPBAR1). Interactions of bile acids with the gut microbiota that result in the altered composition of circulating and intestinal bile acids pool, gut microbiota composition and modified signaling pathways, are further extending the complexity of biological functions of these steroid derivatives. Thus, bile acids signaling pathways have become attractive targets for the treatment of various metabolic diseases and metabolic syndrome opening the new potential avenue in their treatment. In addition, there is a significant effort to unveil some specific properties of bile acids relevant to their intrinsic potency and selectivity for particular receptors and to design novel modulators of these receptors with improved pharmacokinetic and pharmacodynamic profiles. This resulted in synthesis of few semi-synthetic bile acids derivatives such as 6a-ethyl-chenodeoxycholic acid (obeticholic acid, OCA), norursodeoxycholic acid (norUDCA), and 12-monoketocholic acid (12-MKC) that are proven to have positive effect in metabolic and hepato-biliary disorders. This review presents an overview of the current knowledge related to bile acids implications in glucose, lipid and energy metabolism, as well as a potential application of bile acids in metabolic syndrome treatment with future perspectives. 2018 Journal Article http://hdl.handle.net/20.500.11937/74354 10.3389/fphar.2018.01382 http://creativecommons.org/licenses/by/4.0/ fulltext
spellingShingle Danic, M.
Stanimirov, B.
Pavlovic, N.
Golocorbin-Kon, S.
Al-Salami, Hani
Stankov, K.
Mikov, M.
Pharmacological Applications of Bile Acids and Their Derivatives in the Treatment of Metabolic Syndrome
title Pharmacological Applications of Bile Acids and Their Derivatives in the Treatment of Metabolic Syndrome
title_full Pharmacological Applications of Bile Acids and Their Derivatives in the Treatment of Metabolic Syndrome
title_fullStr Pharmacological Applications of Bile Acids and Their Derivatives in the Treatment of Metabolic Syndrome
title_full_unstemmed Pharmacological Applications of Bile Acids and Their Derivatives in the Treatment of Metabolic Syndrome
title_short Pharmacological Applications of Bile Acids and Their Derivatives in the Treatment of Metabolic Syndrome
title_sort pharmacological applications of bile acids and their derivatives in the treatment of metabolic syndrome
url http://hdl.handle.net/20.500.11937/74354